An explainable hypothesis-driven approach to Drug-Induced Liver Injury with HADES

📅 2026-05-04
📈 Citations: 0
Influential: 0
📄 PDF

career value

215K/year
🤖 AI Summary
This study addresses the limited clinical translatability of traditional drug-induced liver injury (DILI) prediction models, which typically rely on opaque binary classification and lack mechanistic interpretability. To overcome this, the work reframes DILI prediction as an interpretable mechanism hypothesis generation task, introducing DILER—the first benchmark dataset annotated with hepatotoxicity mechanism hypotheses—and presenting HADES, an agent-based system that integrates molecular representations, metabolite breakdown, structural similarity, and toxicity pathway evidence to enable transparent, auditable reasoning. Evaluated on the DILER test set, the approach achieves a ROC-AUC of 0.68 (0.59 on the post-2021 subset), significantly outperforming existing models, and establishes the first baseline for mechanism hypothesis generation with a soft Jaccard index of 0.16, thereby pioneering a new paradigm for interpretable DILI prediction.
📝 Abstract
Drug-induced liver injury (DILI) remains a leading cause of late-stage clinical trial attrition. However, existing computational predictors primarily rely on binary classification, a framing that limits generalization and yields no mechanistic insight to guide translational decisions. We argue that DILI prediction is better posed as an explainable hypothesis-generation problem. To support this shift, we introduce the DILER Benchmark, a dataset that extends beyond binary labels by augmenting a curated set of molecules with mechanistic hepatotoxicity hypotheses derived from biomedical literature. We further present HADES, an agentic system designed to generate transparent and auditable reasoning traces. By combining molecular-level predictions, metabolite decomposition, structural understanding, and toxicity pathway evidence, HADES mechanistically assesses DILI risk. Evaluated on the DILER Benchmark, HADES outperforms existing models in binary classification, achieving a ROC-AUC of 0.68 on the Test Set and 0.59 on the challenging Post-2021 Set, compared with 0.63 and 0.50 for DILI-Predictor, respectively. More importantly, we establish a baseline for mechanistic hypothesis generation, where HADES achieves a Hypothesis Alignment Fuzzy Jaccard Index of 0.16. This result underscores the inherent complexity of the task while highlighting the need for advanced explainable approaches in predictive toxicology.
Problem

Research questions and friction points this paper is trying to address.

Drug-Induced Liver Injury
explainable AI
hypothesis generation
mechanistic insight
predictive toxicology
Innovation

Methods, ideas, or system contributions that make the work stand out.

explainable AI
hypothesis generation
drug-induced liver injury
mechanistic toxicology
HADES
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid
M
Maciej Wisniewski
Ingenix.ai, Warsaw, Poland; Laboratory of Bioinformatics and Computational Genomics, Warsaw University of Technology, Warsaw, Poland
B
Bartosz Topolski
Ingenix.ai, Warsaw, Poland
P
Pawel Dabrowski-Tumanski
Ingenix.ai, Warsaw, Poland; Laboratory of Bioinformatics and Computational Genomics, Warsaw University of Technology, Warsaw, Poland
Dariusz Plewczynski
Dariusz Plewczynski
Professor of Bioinformatics, University of Warsaw
Computational GenomicsNucleome 4DBioinformaticsSystems BiologyComputational Intelligence
T
Tomasz Jetka
Ingenix.ai, Warsaw, Poland